SD |
heart rate |
artificial aortocaval fistula (for 5 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
0 days
| 6 |
395.0 |
beats/min |
5.0 |
12.25 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
5 |
days |
98799 |
2160 |
SD |
heart rate |
artificial aortocaval fistula (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
0 days
| 6 |
419.0 |
beats/min |
21.0 |
51.44 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
720 |
min |
98795 |
2160 |
SD |
heart rate |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
98 days
| 8 |
271.0 |
beats/min |
11.0 |
31.11 |
vascular transducer tipped catheter |
0.0 |
ACF |
28 |
days |
99216 |
2278 |
SD |
heart rate |
artificial aortocaval fistula (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
72 days
| 5 |
367.0 |
beats/min |
8.0 |
17.89 |
vascular transducer tipped catheter |
0.0 |
ACF |
2 |
days |
99292 |
2278 |
SD |
heart rate |
sham surgical control condition (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
72 days
| 5 |
371.0 |
beats/min |
4.0 |
8.94 |
vascular transducer tipped catheter |
0.0 |
sham ACF |
2 |
days |
99293 |
2278 |
SD |
heart rate |
sham surgical control condition (between 120 and 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
0 days
| 6 |
365.0 |
beats/min |
15.0 |
36.74 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
5 |
days |
98800 |
2160 |
SD |
heart rate |
artificial aortocaval fistula (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
98 days
| 8 |
316.0 |
beats/min |
3.0 |
8.49 |
vascular transducer tipped catheter |
0.0 |
ACF |
28 |
days |
99298 |
2278 |
SD |
heart rate |
artificial aortocaval fistula (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) then xylazine (10 mg/kg) and ketamine (80 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
0 days
| 6 |
378.0 |
beats/min |
10.0 |
24.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
2 |
days |
98803 |
2160 |
SD |
heart rate |
sham surgical control condition (for 2 days) then metoprolol succinate (100 mg/kg/d) (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
0 days
| 6 |
365.0 |
beats/min |
7.0 |
17.15 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
2 |
days |
98805 |
2160 |
SD |
heart rate |
sham surgical control condition (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
0 days
| 6 |
380.0 |
beats/min |
10.0 |
24.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
2 |
days |
98802 |
2160 |
SD |
heart rate |
sham surgical control condition (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
72 days
| 5 |
359.0 |
beats/min |
6.0 |
13.42 |
vascular transducer tipped catheter |
0.0 |
sham ACF |
2 |
days |
99291 |
2278 |
SD |
heart rate |
sham surgical control condition (for 12 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
0 days
| 6 |
395.0 |
beats/min |
11.0 |
26.94 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
720 |
min |
98796 |
2160 |
SD |
heart rate |
artificial aortocaval fistula (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
0 days
| 6 |
405.0 |
beats/min |
10.0 |
24.49 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
2 |
days |
98797 |
2160 |
SD |
heart rate |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
98 days
| 8 |
260.0 |
beats/min |
12.0 |
33.94 |
vascular transducer tipped catheter |
0.0 |
sham ACF |
28 |
days |
99215 |
2278 |
SD |
heart rate |
artificial aortocaval fistula (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
175 days
| 10 |
220.0 |
beats/min |
5.0 |
15.81 |
vascular transducer tipped catheter |
0.0 |
ACF |
105 |
days |
99218 |
2278 |
SD |
heart rate |
sham surgical control condition (for 105 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
175 days
| 10 |
217.0 |
beats/min |
12.0 |
37.95 |
vascular transducer tipped catheter |
0.0 |
sham ACF |
105 |
days |
99217 |
2278 |
SD |
heart rate |
artificial aortocaval fistula (for 2 days) then Aprotinin (12000 kIU) (for 2 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
72 days
| 5 |
375.0 |
beats/min |
12.0 |
26.83 |
vascular transducer tipped catheter |
0.0 |
ACF |
2 |
days |
99294 |
2278 |
SD |
heart rate |
sham surgical control condition (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) (for 0 hours) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
0 days
| 6 |
385.0 |
beats/min |
11.0 |
26.94 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
360 |
min |
98794 |
2160 |
SD |
heart rate |
artificial aortocaval fistula (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
98 days
| 8 |
307.0 |
beats/min |
3.0 |
8.49 |
vascular transducer tipped catheter |
0.0 |
ACF |
28 |
days |
99296 |
2278 |
SD |
heart rate |
artificial aortocaval fistula (for 6 hours) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
0 days
| 6 |
436.0 |
beats/min |
18.0 |
44.09 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
360 |
min |
98793 |
2160 |
SD |
heart rate |
sham surgical control condition (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
98 days
| 7 |
321.0 |
beats/min |
7.0 |
18.52 |
vascular transducer tipped catheter |
0.0 |
sham ACF |
28 |
days |
99295 |
2278 |
SD |
heart rate |
sham surgical control condition (for 28 days) then Aprotinin (12000 kIU) (for 28 days) |
Wei CC, et al., PLoS One. 2012;7(6):e40110. doi: 10.1371/journal.pone.0040110. Epub 2012 Jun 29. |
heart pumping trait |
male |
98 days
| 7 |
312.0 |
beats/min |
5.0 |
13.23 |
vascular transducer tipped catheter |
0.0 |
sham ACF |
28 |
days |
99297 |
2278 |
SD |
heart rate |
sham surgical control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
0 days
| 6 |
389.0 |
beats/min |
9.0 |
22.05 |
HP Sonos 5500 echo ultrasound |
1.0 |
sham ACF |
2 |
days |
98798 |
2160 |
SD |
heart rate |
artificial aortocaval fistula (for 2 days) then vehicle control condition (for 2 days) then ketamine (80 mg/kg) (for 0 hours) and xylazine (10 mg/kg) |
Seqqat R, et al., J Mol Cell Cardiol. 2012 Aug;53(2):240-9. doi: 10.1016/j.yjmcc.2012.05.004. Epub 2012 May 15. |
heart pumping trait |
male |
0 days
| 6 |
420.0 |
beats/min |
14.0 |
34.29 |
HP Sonos 5500 echo ultrasound |
1.0 |
ACF |
2 |
days |
98801 |
2160 |